Presentation is loading. Please wait.

Presentation is loading. Please wait.

23 March 2011 Madeleine Pearce Chair: SAMED Regulatory Committee

Similar presentations

Presentation on theme: "23 March 2011 Madeleine Pearce Chair: SAMED Regulatory Committee"— Presentation transcript:

1 23 March 2011 Madeleine Pearce Chair: SAMED Regulatory Committee
Medical Devices and Regulations: Feedback from SAMED’s Meeting with Benguela EOH 27 February 2012 23 March 2011 Madeleine Pearce Chair: SAMED Regulatory Committee

SAMED strongly supports a legislative and regulatory framework to control the manufacture, distribution and marketing of medical devices and in-vitro diagnostics (IVDs) to ensure that South African patients have access to products that are safe, effective and of good quality. 2


4 Previously…….

5 Act 72 of 2008 Amended the Medicines and Related Substances Control Act 101 of 1965 Introduced SAHPRA (the South African Health Products Regulatory Authority) Made provisions for the registration of medical devices and in-vitro diagnostics …….. was never brought into law

6 Implementation of SAHPRA
SAHPRA is not likely to be implemented in 2012 Cabinet decision Dec 2011: SAHPRA will be a Schedule 3A Public Entity Medicines and Related Substances Amendment Act (Act 72 of 2008) will be returned to Parliament for an amendment to remove the definition of health product (“product”). Changing legislation takes time (>12 months) With no enabling legislation, implementation of SAHPRA cannot go ahead

7 Benguela Health Was brought in to handle the medicines backlog and design SAHPRA SAMED/SALDA worked on medical device regulations with BH in several workshops Jan-June 2011 Project was put on hold – priorities such as NHI

8 Benguela EOH Project Team
Benguela Health joined EOH Continuation of work done with industry in 2011 and previous years Project secured renewed funding to complete SAHPRA project In 2012, reports to Registrar of Medicines, Mandisa Hela, who is in charge of delivering SAHPRA Legislation update means that the Project Team will not facilitate implementation of SAHPRA but will prepare everything needed to establish and run entity Target of end June 2012 to have all outstanding work completed and packaged for the Minister

9 Health Technology Department NDOH
Sam Bakhane appointed as DDG Terry Downes collating comments from regulations pertaining to Act 101 published in July 2011 Not likely to go any further MAC _HT Advisory Panel for regulation

10 Meeting Benguela/Industry 27 Feb 2012
PART A (All) General feedback Act and amendments Public Entity Structure Food CAMS New Project Team Medicines EDMS eCTD Fees PART B (With core group of device industry players to pick up on the Act 72 device regulations) Devices Regulations

11 Prepare all required to establish and run SAHPRA
Deliverable: Prepare all required to establish and run SAHPRA new establishment must improve situation, must not be ambiguous, must not be subject to corruption - medicines, medical devices, diagnostics, food, complimentary medicine, cosmetics, African traditional medicines, disinfectants Create an Operating Manual for SAHPRA

12 A regulations document – general principles
To support the coming amendment to the Act Attempt to fix gaps in regulation before amended law is enacted Attempt to adapt medicines regulations and guidelines for medical devices/IVDs Cannot refer to international standards Tighter regulation and in detail to prevent too many changes as DOH changes policy (politicians come and go) Offences and penalties are required

13 Discussion Points 27 Feb 2012 SAHPRA Fees
no cross subsidisation from other regulated health products categories estimated 35 line items per product group for registration/per fee payable

14 Discussion Points 27 Feb 2012 Labelling
no special labelling for South Africa international guidelines for device/IVD labelling impact of supply if medicines labelling regime is followed medical device/IVD supply chain is different –to whom are you directing labelling

15 Discussion Points 27 Feb 2012 Authorised Representative
Manufacturer Legal Manufacturer Distributor Agent Consider Medical Device supply chain Multiple agents, retail

16 Discussion Points 27 Feb 2012 Recalls Field Safety Corrective Action
Considerations Role of the Regulator Role of Applicant Time frames

17 Discussion Points 27 Feb 2012 Combination products guideline
Medicines Control Council approach vs International approach

18 Discussion Points 27 Feb 2012 User Defined in the National Health Act
Patient? Health care practitioner? Operator? Defined in the National Health Act “user” means the person receiving treatment in a health establishment, including receiving blood or blood products, or using a health service

19 Documents provided by SAMED
Guidelines on: Establishment Licence Product Registration Medical Device Classification Medical Device Labelling Lodging a complaint for a Medical Device/IVD Recalls and Adverse Events

20 Documents provided by SAMED
International references provided information on: Changes to Registration Clinical Trials Vigilance Reporting Requirements Terminology differences for MDs (PIL, PI, IFU, User Manual) Product evaluations Differentiating handling of capital equipment vs other MDs Implants Custom made devices Conformance Marking Handling of Transition Period, Grandfathering Quality Management Systems Establishment vs device licence

21 Next Steps Meeting with core group 12 April
Regulations document review Discussion on proposed fees vs service level agreements vs capacity Comments on GWP guideline due 30 March Comments on amendment to Act 101 due 15 June 2012

22 Questions

Download ppt "23 March 2011 Madeleine Pearce Chair: SAMED Regulatory Committee"

Similar presentations

Ads by Google